GENÉTICA MOLECULAR DE LA HEMOFILIA A EN UNA FAMILIA COLOMBIANA CON DIAGNÓSTICO DE ENFERMEDAD DE VON WILLEBRAND Y DE HEMOFILIA A

GENÉTICA MOLECULAR DE LA HEMOFILIA A EN UNA FAMILIA COLOMBIANA CON DIAGNÓSTICO DE ENFERMEDAD DE VON WILLEBRAND Y DE HEMOFILIA A

El Factor von Willebrand circula en el plasma formando un complejo con el Factor VIII de coagulación por enlaces no covalentes. Esta interacción evita la degradación enzimática del Factor VIII y asegura su transporte al lugar de formación del coágulo de fibrina. Debido a su estrecha relación, la dis...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Diana Carolina Polanía Villanueva, Diana María Narváez Noguera, Helena Groot de Restrepo
Formaat:	Artikel
Taal:	Spanish
Gepubliceerd in:	Editorial Kimpres 2014-12-01
Reeks:	Medicina
Onderwerpen:	Hemofilia A, Factor VIII, Enfermedad de von Willebrand, Hemophilia A, Factor VIII, von Willebrand disease
Online toegang:	http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/265

Gelijkaardige items

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
door: Castaman G, et al.
Gepubliceerd in: (2016-06-01)

Maltrato infantil, como forma de debut de hemofilia A: presentación de un caso Child abuse, as a form of hemophilia A: presentation of a case
door: Ricardo Busto Aguiar, et al.
Gepubliceerd in: (2011-12-01)

von Willebrand Disease: The diagnosis and management of this bleeding disorder
door: Basim A. Abd, et al.
Gepubliceerd in: (2020-01-01)

[Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease]
door: Giancarlo Castaman
Gepubliceerd in: (2016-06-01)

Desmopressin testing in von Willebrand disease: Lowering the burden
door: Jessica M. Heijdra, et al.
Gepubliceerd in: (2022-08-01)

Von Willebrand's disease: case report and review of literature
door: Hanae Echahdi, et al.
Gepubliceerd in: (2017-06-01)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
door: Gritsch H, et al.
Gepubliceerd in: (2022-11-01)

Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand Disease
door: Michelle Sholzberg, et al.
Gepubliceerd in: (2021-07-01)

Objetivo: describir el manejo médico de tipo hemostático durante el pre, trans y posoperatorio de pacientes con hemofilia y enfermedad de von Willebrand. Materiales y métodos: serie de casos de pacientes diagnosticados con hemofilia A, B, enfermedad de vo
door: Ángela María Peña Castellanos, et al.
Gepubliceerd in: (2011-12-01)

Fixed doses of N8‐GP prophylaxis maintain moderate‐to‐mild factor VIII levels in the majority of patients with severe hemophilia A
door: Pratima Chowdary, et al.
Gepubliceerd in: (2019-07-01)

Hemofilia adquirida
door: Martín Milanesio, et al.
Gepubliceerd in: (2022-03-01)

A Rare Case of Klippel Trenaunay Syndrome with Von Willebrand Factor Deficiency and Multiple Accessory Spleens: A Case Report and Brief Literature Review
door: Vahid Falahati, et al.
Gepubliceerd in: (2024-02-01)

Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow
door: Hiroaki Yaoi, et al.
Gepubliceerd in: (2023-12-01)

Human plasma-derived FVIII/VWD concentrate (Biostate): a review of experimental and clinical pharmacokinetic, efficacy and safety data
door: Paul Harper, et al.
Gepubliceerd in: (2016-04-01)

Hemofilia A adquirida
door: Ana Luísa Albuquerque, et al.
Gepubliceerd in: (2022-06-01)

Current Understanding of Inherited Modifiers of FVIII Pharmacokinetic Variation
door: Swystun LL, et al.
Gepubliceerd in: (2023-03-01)

Desenvolvimento de inibidores do fator VIII na hemofilia A Development of factor VIII inhibitors in hemophilia A
door: Daniel G. Chaves, et al.
Gepubliceerd in: (2009-01-01)

Pharmacokinetics, Efficacy and Safety of a Plasma-Derived VWF/FVIII Concentrate (Formulation V) in Pediatric Patients with von Willebrand Disease (SWIFTLY-VWD Study)
door: Auerswald G, et al.
Gepubliceerd in: (2020-06-01)

Factors VIII and von Willebrand levels in women undergoing Assisted Reproduction: are their levels associated with clinical pregnancy outcome?
door: Monica Attanasio, et al.
Gepubliceerd in: (2020-08-01)

Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study)
door: Djambas Khayat C, et al.
Gepubliceerd in: (2021-06-01)

Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study
door: Carmen Escuriola Ettingshausen, et al.
Gepubliceerd in: (2022-04-01)

Hemofilia II. Aspectos moleculares y de genética poblacional Hemophilia II. Molecular and population genetics
door: Dunia Castillo-González
Gepubliceerd in: (2012-06-01)

The Molecular Genetics of von Willebrand Disease
door: Ergül Berber
Gepubliceerd in: (2012-12-01)

A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9
door: Jessica Garcia, et al.
Gepubliceerd in: (2020-01-01)

Influence of canine donor plasma hemostatic protein concentration on quality of cryoprecipitate
door: Macy Drinkhouse, et al.
Gepubliceerd in: (2019-01-01)

Perioperative management of a pediatric patient with suspected type 1 von Willebrand disease undergoing tonsillectomy: a case report
door: Hiroyuki Oshika, et al.
Gepubliceerd in: (2019-08-01)

Increased von Willebrand and Factor VIII plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVID
door: Stefania Bellone, et al.
Gepubliceerd in: (2024-02-01)

Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
door: Bauer A, et al.
Gepubliceerd in: (2023-06-01)

Clinical Utility of Subcutaneous Factor VIII Replacement Therapies in Hemophilia A: A Review of the Evidence
door: Dargaud Y, et al.
Gepubliceerd in: (2021-12-01)

MANEJO INTRAPARTO DE EMBARAZADAS CON TRASTORNOS HEREDITARIOS DE LA COAGULACIÓN
door: Paulina Merino O, et al.
Gepubliceerd in: (2006-01-01)

Patient with von Willebrand Disease for Gynaecologic Surgery - Perianaesthetic Concerns
door: Rakesh Garg, et al.
Gepubliceerd in: (2008-01-01)

Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia
door: Monica Sacco, et al.
Gepubliceerd in: (2020-03-01)

Recombinant von Willebrand Factor for Pediatric Patient with von Willebrand Disease: First Report in Korea
door: Seoin Kim, et al.
Gepubliceerd in: (2021-04-01)

Hemofilia A adquirida associada à artrite reumatoide Acquired hemophilia associated with rheumatoid arthritis
door: Marlene Freire, et al.
Gepubliceerd in: (2009-06-01)

INVESTIGATION OF RISTOCETIN-INDUCED PLATELET AGGREGATION, PARAMETERS OF VON WILLEBRAND FACTOR AND THE COAGULATION FACTOR VIII AT ESSENTIAL ARTERIAL HYPERTENSION IN CHILDREN
door: M. V. Gomellya
Gepubliceerd in: (2014-02-01)

Hemofilia A neonatal: reporte de un caso en Sincelejo (Colombia)
door: Jorge Mendoza-Herrera, et al.
Gepubliceerd in: (2013-01-01)

Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
door: Daniel Simon, et al.
Gepubliceerd in: (2003-12-01)

Multiple Sclerosis Diagnosed in a Woman With Von-Willebrand Disease: A Case Report
door: Mohsen Farjoud Kouhanjani, et al.
Gepubliceerd in: (2022-07-01)

Analysis of von Willebrand Disease in the “Heart of Europe”
door: Inge Vangenechten, et al.
Gepubliceerd in: (2022-10-01)

Switch to pdVWF:pdFVIII concentrate for prophylaxis in a paediatric patient with Type 3 von Willebrand disease: a case report
door: Claire Berger, et al.
Gepubliceerd in: (2023-12-01)